Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celanese (CE) Asset Writedowns and Impairment (2016 - 2025)

Celanese's Asset Writedowns and Impairment history spans 13 years, with the latest figure at $27.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 98.31% year-over-year to $27.0 million; the TTM value through Dec 2025 reached $3.1 billion, up 91.31%, while the annual FY2025 figure was $1.5 billion, 7.69% down from the prior year.
  • Asset Writedowns and Impairment reached $27.0 million in Q4 2025 per CE's latest filing, down from $1.5 billion in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.6 billion in Q4 2024 to a low of $1.0 million in Q1 2021.
  • Average Asset Writedowns and Impairment over 5 years is $289.4 million, with a median of $9.0 million recorded in 2023.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 26566.67% in 2024, then tumbled 98.31% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $1.0 million in 2021, then skyrocketed by 100.0% to $2.0 million in 2022, then skyrocketed by 200.0% to $6.0 million in 2023, then skyrocketed by 26566.67% to $1.6 billion in 2024, then crashed by 98.31% to $27.0 million in 2025.
  • Per Business Quant, the three most recent readings for CE's Asset Writedowns and Impairment are $27.0 million (Q4 2025), $1.5 billion (Q3 2025), and $1.6 billion (Q4 2024).